Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Tuberculosis (Edinburgh, Scotland)
|
March 24, 2012
Rational approach to selection and clinical development of TB vaccine candidates
Lew Barker, Luc Hessel, Barry Walker
Vaccine
|
April 20, 2013
Preventive vaccines for tuberculosis
Thomas G Evans, Michael J Brennan, Lew Barker, et al.
BMJ (Clinical Research Ed.)
|
November 15, 2008
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial
Anthony Hawkridge, Mark Hatherill, Francesca Little, et al.
Clinical and Vaccine Immunology : CVI
|
August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG
Helen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
Ebiomedicine
|
June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
Daniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Tuberculosis (Edinburgh, Scotland)
|
March 24, 2012
Rational approach to selection and clinical development of TB vaccine candidates
Lew Barker, Luc Hessel, Barry Walker
Vaccine
|
April 20, 2013
Preventive vaccines for tuberculosis
Thomas G Evans, Michael J Brennan, Lew Barker, et al.
BMJ (Clinical Research Ed.)
|
November 15, 2008
Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial
Anthony Hawkridge, Mark Hatherill, Francesca Little, et al.
Clinical and Vaccine Immunology : CVI
|
August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG
Helen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
Ebiomedicine
|
June 21, 2016
Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
Daniel F Hoft, Azra Blazevic, Asmir Selimovic, et al.
Page
of 1